Eve Biomedical Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Eve Biomedical General Information
Description
Provider of biotechnology services intended to offer genomic and personalized medicines. The company's services offer a compact DNA sequencing system that will be able to sequence the whole human genome at lower costs thus helping to break the barrier of introducing sequencing in clinical diagnostics and jump-start the era of genomic medicine, enabling healthcare professionals to develop advanced methods of diagnosis.
Contact Information
Website
www.evebiomedical.comCorporate Office
- 67 East Evelyn Avenue
- Suite 5
- Mountain View, CA 94041
- United States
Corporate Office
- 67 East Evelyn Avenue
- Suite 5
- Mountain View, CA 94041
- United States
Eve Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Feb-2019 | Completed | Out of Business | |||
| 3. Grant | 01-Jan-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 20-Dec-2012 | $5.85M | $7.63M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 04-May-2012 | $1.78M | $1.78M | Completed | Generating Revenue |
Eve Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Eve Biomedical Patents
Eve Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014218911-A1 | Methods and compositions for nanostructure-based nucleic acid sequencing | Active | 20-Feb-2013 | ||
| AU-2014218911-B2 | Methods and compositions for nanostructure-based nucleic acid sequencing | Inactive | 20-Feb-2013 | ||
| CA-2900921-A1 | Methods and compositions for nanostructure-based nucleic acid sequencing | Inactive | 20-Feb-2013 | ||
| EP-2958927-A2 | Methods and compositions for nanostructure-based nucleic acid sequencing | Inactive | 20-Feb-2013 | ||
| EP-2958927-A4 | Methods and compositions for nanostructure-based nucleic acid sequencing | Inactive | 20-Feb-2013 | C12Q1/6869 |
Eve Biomedical Signals
Eve Biomedical FAQs
-
When was Eve Biomedical founded?
Eve Biomedical was founded in 2006.
-
Where is Eve Biomedical headquartered?
Eve Biomedical is headquartered in Mountain View, CA.
-
What is the size of Eve Biomedical?
Eve Biomedical has 11 total employees.
-
What industry is Eve Biomedical in?
Eve Biomedical’s primary industry is Biotechnology.
-
Is Eve Biomedical a private or public company?
Eve Biomedical is a Private company.
-
What is Eve Biomedical’s current revenue?
The current revenue for Eve Biomedical is .
-
How much funding has Eve Biomedical raised over time?
Eve Biomedical has raised $7.63M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process